These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 27870678)

  • 21. Interventional radiological treatment of hepatocellular carcinoma.
    Davis CR
    Cancer Control; 2010 Apr; 17(2):87-99. PubMed ID: 20404792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging features following transarterial chemoembolization and radiofrequency ablation of hepatocellular carcinoma.
    Brennan IM; Ahmed M
    Semin Ultrasound CT MR; 2013 Aug; 34(4):336-51. PubMed ID: 23895906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interventional radiology for hepatocellular carcinoma.
    Loffroy R
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):299-309. PubMed ID: 21769079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.
    Miura JT; Gamblin TC
    Surg Oncol Clin N Am; 2015 Jan; 24(1):149-66. PubMed ID: 25444473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the response to locoregional and systemic treatment for hepatocellular carcinoma.
    Darnell A; Belmonte E; Reig M; Brú C
    Radiologia (Engl Ed); 2018; 60(5):424-436. PubMed ID: 30196841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
    Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS
    Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status.
    Chen L; Sun J; Yang X
    Cancer Lett; 2016 Jan; 370(1):78-84. PubMed ID: 26472630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interventional radiology in oncology: clinical management of patients undergoing transarterial chemoembolization for hepatic malignancies.
    Perez-Rojas E
    Clin J Oncol Nurs; 2012 Feb; 16(1):83-5. PubMed ID: 22297011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination Therapies in the Management of Large (≥ 5 cm) Hepatocellular Carcinoma: Microwave Ablation Immediately Followed by Transarterial Chemoembolization.
    Si ZM; Wang GZ; Qian S; Qu XD; Yan ZP; Liu R; Wang JH
    J Vasc Interv Radiol; 2016 Oct; 27(10):1577-83. PubMed ID: 27103146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the treatment response of HCC.
    Kim KW; Lee JM; Choi BI
    Abdom Imaging; 2011 Jun; 36(3):300-14. PubMed ID: 21279353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbon dioxide-enhanced sonographically guided radiofrequency ablation plus transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    J Vasc Interv Radiol; 2006 Apr; 17(4):723-6. PubMed ID: 16614157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Kis B; El-Haddad G; Sheth RA; Parikh NS; Ganguli S; Shyn PB; Choi J; Brown KT
    Cancer Control; 2017; 24(3):1073274817729244. PubMed ID: 28975829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging assessment of hepatocellular carcinoma response to locoregional and systemic therapy.
    Yaghmai V; Besa C; Kim E; Gatlin JL; Siddiqui NA; Taouli B
    AJR Am J Roentgenol; 2013 Jul; 201(1):80-96. PubMed ID: 23789661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interventional Radiologic Treatment of Hepatocellular Carcinoma.
    Boyvat F
    Exp Clin Transplant; 2017 Mar; 15(Suppl 2):25-30. PubMed ID: 28301995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transarterial Chemoembolization in Combination with a Molecular Targeted Agent: Lessons Learned from Negative Trials (Post-TACE, BRISK-TA, SPACE, ORIENTAL, and TACE-2).
    Kudo M; Arizumi T
    Oncology; 2017; 93 Suppl 1():127-134. PubMed ID: 29258086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in the treatment of hepatocellular carcinoma.
    Padhya KT; Marrero JA; Singal AG
    Curr Opin Gastroenterol; 2013 May; 29(3):285-92. PubMed ID: 23507917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PET/Computed Tomography in Evaluation of Transarterial Chemoembolization.
    Ortega López N
    PET Clin; 2015 Oct; 10(4):507-17. PubMed ID: 26384597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation.
    Ginsburg M; Zivin SP; Wroblewski K; Doshi T; Vasnani RJ; Van Ha TG
    J Vasc Interv Radiol; 2015 Mar; 26(3):330-41. PubMed ID: 25534635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transarterial therapies for hepatocellular carcinoma.
    Sangro B; D'Avola D; Iñarrairaegui M; Prieto J
    Expert Opin Pharmacother; 2011 May; 12(7):1057-73. PubMed ID: 21470073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology.
    Bargellini I; Florio F; Golfieri R; Grosso M; Lauretti DL; Cioni R
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):438-44. PubMed ID: 23719667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.